Financhill
Back

Astria Therapeutics Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Sell
19

ATXS
Astria Therapeutics

Last Price:
9.50
Seasonality Move:
-21.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See

Astria Therapeutics Price Quote

$9.50
+0.32 (+3.49%)
(Updated: May 1, 2024 at 6:55 PM ET)

Astria Therapeutics Key Stats

Sell
19
Astria Therapeutics (ATXS) is a Sell

Day range:
$9.01 - $9.29
52-week range:
$4.26 - $16.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.41%

Volume:
534K
Avg. volume:
1.1M
1-year change:
-29.66%
Market cap:
$504M
Revenue:
$0
EPS:
$-2.42

How Much Does Astria Therapeutics Make?

Data Unavailable

Is Astria Therapeutics Growing As A Company?

Data Unavailable

Astria Therapeutics Stock Price Performance

What Is Astria Therapeutics 52-Week High & Low?

Astria Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astria Therapeutics?

Is Astria Therapeutics Cash Flow Positive?

  • What Is ATXS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.4M
  • What Is Astria Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.4M
  • What Is Astria Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $135.1M

Astria Therapeutics Return On Invested Capital

Data Unavailable

Astria Therapeutics Earnings Date & Stock Price

Astria Therapeutics Competitors

Astria Therapeutics Dividend Yield

Data Unavailable

Astria Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 25.29
Upside from Last Price: 175.44%

Major Shareholders

  • How many ATXS shares are owned by institutional investors?
    56.7M ATXS shares are owned by institutional investors
  • How many ATXS shares are owned by insiders?
    767.8K ATXS shares are owned by insiders